0 selected

Hormone Balance (Vitex / Chasteberry)

The most-searched 'hormone balance' herb for women — with real trial evidence for some uses and honestly weaker evidence for others.

The short answerEvidence is real but condition-specific
Stronger evidence Best-supported use PMS / PMDD

A systematic review of 13 randomized controlled trials found consistent benefit for PMS symptoms, PMDD, and latent hyperprolactinemia specifically — this is where Vitex's evidence is strongest.

Weaker evidence Weaker-supported use Menopause

Mixed. Some individual RCTs found Vitex reduced menopausal symptoms; a separate larger 16-week RCT (Vitex + St. John's Wort) found no benefit over placebo for hot flashes or depression.

What it is, and why people take it

Vitex agnus-castus (chasteberry) is an herbal extract believed to act on the pituitary gland, modestly lowering prolactin and indirectly influencing the estrogen-progesterone balance across the menstrual cycle.

People take it for PMS symptoms, irregular luteal-phase length, and — more controversially — menopausal symptoms.

It's one of the few 'hormone balance' supplements with a real body of randomized trials behind it, which also means it's possible to see where the evidence is strong versus where it's thin.

Sources 4 studies · show list
  1. Van Die, Burger, Teede, Bone (2013). Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Medica. PubMed 23136064 Flagged in the evidence above
  2. Naseri, Farnia, Yazdchi, Alikhani, Basanj, Salemi (2019). Comparison of Vitex agnus-castus Extracts with Placebo in Reducing Menopausal Symptoms: RCT. Korean Journal of Family Medicine. PubMed 31067851
  3. Milewicz, Gejdel, Sworen, Sienkiewicz, Jedrzejak, Teucher, Schmitz (1993). Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia: RCT. Arzneimittelforschung. PubMed 8369008
  4. Sopjani, Murati, Mataj-Berisha, Xuan, Faggio, Rifati-Nixha (2026). Vitex agnus-castus in Menopause: Phytochemistry, Mechanistic Insights, Clinical Applications, and Safety Perspectives. Phytotherapy Research. PubMed 41630367
4 sources cited — RMIT, Prince Henry's Institute, Monash University, University of Prishtina, and others. One co-author on the foundational 2013 review is also affiliated with MediHerb, a commercial herbal supplement manufacturer — see flag below.Sources last checked against the published papers on 11 September 2026.